ENBIO Co., Ltd. (KOSDAQ:352940)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,015.00
0.00 (0.00%)
At close: Jun 9, 2026

ENBIO Revenue

ENBIO had revenue of 14.14B KRW in the quarter ending March 31, 2026, with 2.24% growth. This brings the company's revenue in the last twelve months to 34.26B, up 1.15% year-over-year. In the year 2025, ENBIO had annual revenue of 33.95B, down -4.77%.

Revenue (ttm)
34.26B
Revenue Growth
+1.15%
P/S Ratio
0.63
Revenue / Employee
428.29M
Employees
80
Market Cap
21.69B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202533.95B-1.70B-4.77%
Dec 31, 202435.65B1.63B4.79%
Dec 31, 202334.02B-215.53M-0.63%
Dec 31, 202234.24B773.80M2.31%
Dec 31, 202133.47B-1.10B-3.17%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Samjin LND132.46B
CU Medical Systems54.66B
Nano Chem Tech50.17B
Logisys47.60B
Finetek45.17B
VALOFE Co.,Ltd40.05B
Alton31.33B
SoftCamp26.29B
Revenue Rankings